CARDIOVASCULAR RISK-FACTORS IN CHRONIC-RENAL-FAILURE AND HEMODIALYSIS POPULATIONS

被引:249
|
作者
MA, KW
GREENE, EL
RAIJ, L
机构
[1] VET ADM MED CTR, DEPT MED, 1 VET DR, MINNEAPOLIS, MN 55417 USA
[2] UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA
关键词
CARDIOVASCULAR RISK FACTORS; CHRONIC RENAL FAILURE; HYPERTENSION; DYSLIPOPROTEINEMIA; LVH; GLUCOSE INTOLERANCE;
D O I
10.1016/S0272-6386(12)80827-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of death in patients with end-stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study. © 1992, National Kidney Foundation. All rights reserved.. All rights reserved.
引用
收藏
页码:505 / 513
页数:9
相关论文
共 50 条
  • [31] PHARMACOKINETICS AND EFFICACY OF CARVEDILOL IN HYPERTENSIVE PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEMODIALYSIS-PATIENTS
    MASUMURA, H
    MIKI, S
    KAIFU, Y
    KITAJIMA, W
    ABE, Y
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S102 - S107
  • [32] MALIGNANT DISEASES IN CHRONIC-RENAL-FAILURE
    FELIPE, C
    MARCEN, R
    NAYA, MT
    MORENO, R
    OROFINO, L
    ORTUNO, J
    NEFROLOGIA, 1993, 13 (01): : 30 - 36
  • [33] CYTOMEGALOVIRUS COLITIS IN CHRONIC-RENAL-FAILURE
    ESFORZADO, N
    POCH, E
    ALMIRALL, J
    BOMBI, JA
    LOPEZPEDRET, J
    REVERT, L
    CLINICAL NEPHROLOGY, 1993, 39 (05) : 275 - 278
  • [34] ENDOTHELIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    NEMECEK, K
    BARTOVA, V
    JACHYMOVA, M
    HORKY, K
    RENAL FAILURE, 1995, 17 (05) : 559 - 563
  • [35] LIPIDS IN THE PROGRESSION OF CHRONIC-RENAL-FAILURE
    CAPPELLI, P
    EVANGELISTA, M
    BONOMINI, M
    PALMIERI, PF
    ALBERTAZZI, A
    NEPHRON, 1992, 62 (01): : 31 - 35
  • [36] CARDIOVASCULAR RISK-FACTORS IN SCHOOLCHILDREN
    MICHEL, U
    RIECHERS, B
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1992, 11 : S36 - S40
  • [37] Incidence and risk factors of atherosclerotic cardiovascular accidents in dialysis chronic renal failure patients
    Tatjana, Djurdjevic Mirkovic
    Sinisa, Mirkovic
    Ljiljana, Gvozdenovic
    Lada, Petrovic
    Dejan, Celic
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (07) : E88 - E88
  • [38] SNORING AND CARDIOVASCULAR RISK-FACTORS
    KOSKENVUO, M
    PARTINEN, M
    KAPRIO, J
    VUORINEN, H
    TELAKIVI, T
    KAJASTE, S
    SALMI, T
    HEIKKILA, K
    ANNALS OF MEDICINE, 1994, 26 (05) : 371 - 376
  • [39] A STUDY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF CHRONIC-RENAL-FAILURE IN CHILDREN ON HEMODIALYSIS
    VANDAMMELOMBAERTS, R
    BROYER, M
    BUSINGER, J
    BALDAUF, C
    STOCKER, H
    PEDIATRIC NEPHROLOGY, 1994, 8 (03) : 338 - 342
  • [40] RISK-FACTORS FOR CARDIOVASCULAR-DISEASE AFTER RENAL-TRANSPLANTATION
    KASISKE, BL
    MINERAL AND ELECTROLYTE METABOLISM, 1993, 19 (03) : 186 - 195